Leptin resistance of adipocytes in obesity: Role of suppressors of cytokine signaling

被引:94
作者
Wang, ZW
Zhou, YT
Kakuma, T
Lee, Y
Kalra, SP
Kalra, PS
Pan, WT
Unger, RH
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Touchstone Ctr Diabet Res,Gifford Labs, Dallas, TX 75390 USA
[2] VA N Texas Hlth Care Syst, Dallas, TX 75216 USA
[3] Univ Florida, Sch Med, Dept Neurosci, Gainesville, FL 32610 USA
关键词
obesity; leptin resistance; SOCS; direct leptin action; endocrine autosuppression;
D O I
10.1006/bbrc.2000.3615
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Liver-derived hyperleptinemia induced in normal rats by adenovirus-induced gene transfer causes rapid disappearance of body fat, whereas the endogenous adipocyte-derived hyperleptinemia of obesity does not. Here we induce liver-derived hyperleptinemia in rats with adipocyte-derived hyperleptinemia of acquired obesity caused by ventromedial hypothalamus lesioning (VMH rats) or by feeding 60% fat (DIO rats). Liver-derived hyperleptinemia in obese rats caused only a 5-7% loss of body weight, compared to a 13% loss in normoleptinemic lean animals; but in actual grams of weight lost there was no significant difference between obese and lean groups, suggesting that a subset of cells remain leptin-sensitive in obesity, mRNA and protein of a putative leptin-resistance factor, suppressor of cytokine signaling (SOCS)-1 or -3, were both increased in white adipose tissues (WAT) of VHM and DIO rats. Since transgenic overexpression of SOCS-3 in islets reduced the lipopenic effect of leptin by 75%, we conclude that the increased expression of SOCS-1 and -3 in WAT of rats with acquired obesity could have blocked leptin's lipopenic action in the leptin-resistant WAT population. (C) 2000 Academic Press.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 16 条
[1]
Identification of SOCS-3 as a potential mediator of central leptin resistance [J].
Bjorbaek, C ;
Elmquist, JK ;
Frantz, JD ;
Shoelson, SE ;
Flier, JS .
MOLECULAR CELL, 1998, 1 (04) :619-625
[2]
The role of SOCS-3 in leptin signaling and leptin resistance [J].
Bjorbæk, C ;
El-Haschimi, K ;
Frantz, JD ;
Flier, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30059-30065
[3]
Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor [J].
Carpenter, LR ;
Farruggella, TJ ;
Symes, A ;
Karow, ML ;
Yancopoulos, GD ;
Stahl, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6061-6066
[4]
Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy [J].
Chen, GX ;
Koyama, K ;
Yuan, X ;
Lee, Y ;
Zhou, YT ;
ODoherty, R ;
Newgard, CB ;
Unger, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14795-14799
[5]
Specific inhibition of Stat3 signal transduction by PIAS3 [J].
Chung, CD ;
Liao, JY ;
Liu, B ;
Rao, XP ;
Jay, P ;
Berta, P ;
Shuai, K .
SCIENCE, 1997, 278 (5344) :1803-1805
[6]
SENSITIVITY OF INSULIN-SECRETION TO FEEDBACK INHIBITION BY HYPERINSULINEMIA [J].
DEFRONZO, RA ;
BINDER, C ;
WAHREN, J ;
FELIG, P ;
FERRANNINI, E ;
FABER, OK .
ACTA ENDOCRINOLOGICA, 1981, 98 (01) :81-86
[7]
FUNCTIONAL-ACTIVITY OF MYOGENIC HLH PROTEINS REQUIRES HETERO-OLIGOMERIZATION WITH E12/E47-LIKE PROTEINS INVIVO [J].
LASSAR, AB ;
DAVIS, RL ;
WRIGHT, WE ;
KADESCH, T ;
MURRE, C ;
VORONOVA, A ;
BALTIMORE, D ;
WEINTRAUB, H .
CELL, 1991, 66 (02) :305-315
[8]
BETA-CELL LIPOTOXICITY IN THE PATHOGENESIS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS OF OBESE RATS - IMPAIRMENT IN ADIPOCYTE-BETA-CELL RELATIONSHIPS [J].
LEE, Y ;
HIROSE, H ;
OHNEDA, M ;
JOHNSON, JH ;
MCGARRY, JD ;
UNGER, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :10878-10882
[9]
LEPTIN LEVELS IN HUMAN AND RODENT - MEASUREMENT OF PLASMA LEPTIN AND OB RNA IN OBESE AND WEIGHT-REDUCED SUBJECTS [J].
MAFFEI, M ;
HALAAS, J ;
RAVUSSIN, E ;
PRATLEY, RE ;
LEE, GH ;
ZHANG, Y ;
FEI, H ;
KIM, S ;
LALLONE, R ;
RANGANATHAN, S ;
KERN, PA ;
FRIEDMAN, JM .
NATURE MEDICINE, 1995, 1 (11) :1155-1161
[10]
INSULIN WITHIN ISLETS IS A PHYSIOLOGIC GLUCAGON-RELEASE INHIBITOR [J].
MARUYAMA, H ;
HISATOMI, A ;
ORCI, L ;
GRODSKY, GM ;
UNGER, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2296-2299